Table 2.

Effect of cryoablation vs. radical prostatectomy on oncologic outcomes.

Cancer-specific survival	HR	95%CI	P-value
In adjusted non-matched cohort	2.32	1.54–3.50	<0.001
In adjusted matched cohort	2.07	1.22–3.51	0.007
In adjusted SMRW model	2.66	1.27–5.59	0.010
Overall survival	HR	95%CI	P-value
In adjusted non-matched cohort	2.34	2.07–2.64	<0.001
In adjusted matched cohort	2.09	1.80–2.44	<0.001
In adjusted SMRW model	2.29	1.85–2.83	<0.001

HR, hazard ratio; CI, confidence interval; SMRW, standardized mortality ratio weighting.